We next tested whether the peptide f-MVPIKI and its derivatives could induce intracellular Ca2+ release in the human glioblastoma cell line U87-MG that is known to express FPR1, FPR3 and trace amounts of FPR239 (Supplement 2). Here, FPR3 is linked to glioblastoma.